1-(4-(2,3-Dihydro-3-methyl-2-oxo-1H-imidazo[4,5-b]pyridin-7-yl-oxy)phenyl)-3-(4-chloro-3-(trifluoromethyl)phenyl)urea

ID: ALA523129

Cas Number: 884339-66-6

PubChem CID: 11719900

Max Phase: Preclinical

Molecular Formula: C21H15ClF3N5O3

Molecular Weight: 477.83

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1c(=O)[nH]c2c(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)ccnc21

Standard InChI:  InChI=1S/C21H15ClF3N5O3/c1-30-18-17(29-20(30)32)16(8-9-26-18)33-13-5-2-11(3-6-13)27-19(31)28-12-4-7-15(22)14(10-12)21(23,24)25/h2-10H,1H3,(H,29,32)(H2,27,28,31)

Standard InChI Key:  MNCDHOPLKWNXCF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   10.7280  -24.3153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7268  -25.1434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4423  -25.5565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4405  -23.9022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1563  -24.3117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1612  -25.1434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9538  -25.3958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4388  -24.7200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9459  -24.0501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.2644  -24.7151    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4380  -23.0765    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.7230  -22.6505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7310  -21.8255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0191  -21.4086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3008  -21.8173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2986  -22.6473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0110  -23.0604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5876  -21.4013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5913  -20.5756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8781  -20.1596    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3082  -20.1660    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1610  -20.5652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4517  -20.1483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7350  -20.5568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7361  -21.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4481  -21.7998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1618  -21.3889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2135  -26.1795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0195  -21.7899    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.4437  -22.6254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4385  -23.4480    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.2693  -22.6302    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.6180  -22.6237    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 15 16  1  0
  6  7  1  0
 16 17  2  0
 17 12  1  0
  7  8  1  0
 15 18  1  0
  8  9  1  0
 18 19  1  0
  9  5  1  0
 19 20  1  0
  4  1  1  0
 19 21  2  0
  8 10  2  0
 20 22  1  0
  5  6  1  0
 22 23  2  0
  4 11  1  0
 23 24  1  0
 24 25  2  0
 11 12  1  0
 25 26  1  0
  2  3  1  0
 26 27  2  0
 27 22  1  0
 12 13  2  0
  7 28  1  0
  3  6  2  0
 25 29  1  0
 13 14  1  0
 26 30  1  0
  1  2  2  0
 30 31  1  0
 14 15  2  0
 30 32  1  0
  5  4  2  0
 30 33  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Muscle (539 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 477.83Molecular Weight (Monoisotopic): 477.0816AlogP: 5.37#Rotatable Bonds: 4
Polar Surface Area: 101.04Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.49CX Basic pKa: 2.77CX LogP: 4.69CX LogD: 4.69
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.37Np Likeness Score: -1.43

References

1. Niculescu-Duvaz D, Gaulon C, Dijkstra HP, Niculescu-Duvaz I, Zambon A, Ménard D, Suijkerbuijk BM, Nourry A, Davies L, Manne H, Friedlos F, Ogilvie L, Hedley D, Whittaker S, Kirk R, Gill A, Taylor RD, Raynaud FI, Moreno-Farre J, Marais R, Springer CJ..  (2009)  Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF).,  52  (8): [PMID:19323560] [10.1021/jm801509w]

Source